Mechanism of inflammatory diseases
The purpose of this licence is to identify novel immune mechanisms and thus lead to the development of new medicines to treat inflammatory diseases such as rheumatoid arthritis, asthma and multiple sclerosis.
Date: Tue Aug 29 14:18:16 BST 2006
